DeepMed Research

Turku University Hospital

🇫🇮Finland

Country: 🇫🇮Finland

Ownership: Subsidiary

Established: 1756-01-01

Employees: -

Market Cap: -

Website: http://www.vsshp.fi

Clinical Trials

Bioavailability of Intranasal Dexmedetomidine

Phase 4

Completed

Conditions: Anesthesia
Pharmacokinetics
Arthritis of Hip
Arthritis Knee

Interventions: Device: Dexmedetomidine

First Posted Date: 2021-10-04

Last Posted Date: 2022-05-17

Lead Sponsor: Turku University Hospital

Target Recruit Count: 30

Registration Number: NCT05065775

Locations: 🇫🇮
Perioperative Services, Intensive Care and Pain Therapy, Turku University Hospital and University of Turku, Turku, Finland

Long-term Results of Tonsillectomy in the Treatment of Obstructive Sleep Apnea in Adults

Not Applicable

Completed

Conditions: Obstructive Sleep Apnea
Sleep Apnea Syndromes
Tonsillar Hypertrophy

Interventions: Device: Polysomnography

First Posted Date: 2021-09-20

Last Posted Date: 2023-12-26

Lead Sponsor: Turku University Hospital

Target Recruit Count: 17

Registration Number: NCT05049369

Locations: 🇫🇮
Turku University Hospital, Turku, Southwest Finland, Finland

Safety and Efficacy of HA380 Hemoadsorption in Patients With Septic Shock

Not Applicable

Recruiting

Conditions: Acute Kidney Injury
Septic Shock

Interventions: Device: Combined HA380 hemoadsorption and continuous veno-venous hemodiafiltration (CVVHDF) with Oxiris®-AN69 membranes
Device: Continuous veno-venous hemodiafiltration (CVVHDF) with Oxiris®-AN69 membranes

First Posted Date: 2021-08-09

Last Posted Date: 2021-08-09

Lead Sponsor: Turku University Hospital

Target Recruit Count: 40

Registration Number: NCT04997421

Locations: 🇫🇮
Turku University Hospital, Turku, Finland

Exercise and Tumor Blood Flow in Lymphoma And Breast Cancer Patients (EXETUMOR 3)

Not Applicable

Conditions: Tumor

Interventions: Procedure: Exercise

First Posted Date: 2021-08-05

Last Posted Date: 2021-08-05

Lead Sponsor: Turku University Hospital

Target Recruit Count: 28

Registration Number: NCT04990856

Locations: 🇫🇮
Turku PET Centre, Turku, Finland

Postoperative Pain Relief With Transversus Thoracis Muscle Plane Block After Cardiac Surgery

Phase 4

Completed

Conditions: Pain, Postoperative
Anesthesia, Local
Coronary Artery Disease
Heart Valve Diseases

Interventions: Drug: Placebo
Drug: Ropivacaine

First Posted Date: 2021-06-07

Last Posted Date: 2025-04-13

Lead Sponsor: Turku University Hospital

Target Recruit Count: 120

Registration Number: NCT04916418

Locations: 🇫🇮
Perioperative Services, Intensive Care and Pain Therapy, Turku University Hospital and University of Turku, Turku, Finland

68Ga-NODAGA-RGD PET in Patients With an Occluded Coronary Artery

Not Applicable

Conditions: Coronary Artery Disease

Interventions: Diagnostic Test: 68Ga-NODAGA-RGD PET-imaging

First Posted Date: 2021-05-04

Last Posted Date: 2022-03-22

Lead Sponsor: Turku University Hospital

Target Recruit Count: 60

Registration Number: NCT04871217

Locations: 🇫🇮
Turku University Hospital, Turku, Finland
🇨🇭
University of Lausanne Hospitals, Lausanne, Switzerland
🇳🇱
Leiden Medical Center, Leiden, Netherlands

Premedication with Intranasal Dexmedetomidine in Sedation of Patients Undergoing Total Knee Arthroplasty

Phase 4

Completed

Conditions: Knee Osteoarthritis
Pain, Postoperative

Interventions: Drug: Dexmedetomidine
Drug: Placebo

First Posted Date: 2021-04-26

Last Posted Date: 2025-01-22

Lead Sponsor: Turku University Hospital

Target Recruit Count: 100

Registration Number: NCT04859283

Locations: 🇫🇮
Perioperative Services, Intensive Care and Pain Therapy, Turku University Hospital and University of Turku, Turku, Finland

Interaction of Sleep, Diurnal Eating Pattern, Gut Microbiota, and Obesity

Not Applicable

Recruiting

Conditions: Obesity

Interventions: Other: Mobile app

First Posted Date: 2021-04-20

Last Posted Date: 2022-06-16

Lead Sponsor: Turku University Hospital

Target Recruit Count: 120

Registration Number: NCT04850391

Locations: 🇫🇮
Turku University Hospital, Turku, Finland

Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC

Not Applicable

Recruiting

Conditions: High Grade Ovarian Serous Adenocarcinoma
High Grade Serous Carcinoma

Interventions: Genetic: WGS and RNA sequencing
Genetic: circulating tumor DNA (ctDNA)
Diagnostic Test: FDG PET/CT imaging

First Posted Date: 2021-04-15

Last Posted Date: 2025-01-16

Lead Sponsor: Turku University Hospital

Target Recruit Count: 200

Registration Number: NCT04846933

Locations: 🇫🇮
Turku University Hospital, Turku, Finland

Open-Label Prospective Study Comparing Long-Term Outcome With or Without HFNC in Patients With Stable Hypercapnic COPD

Not Applicable

Conditions: COPD

Interventions: Device: HFNC Airvo
Other: Standard care

First Posted Date: 2021-04-12

Last Posted Date: 2022-06-16

Lead Sponsor: Turku University Hospital

Target Recruit Count: 94

Registration Number: NCT04840706

Locations: 🇫🇮
Turku University Hospital, Turku, Finland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy